U-47700 and Its Analogs: Non-Fentanyl Synthetic Opioids Impacting the Recreational Drug Market
Open Access
- 23 November 2020
- journal article
- review article
- Published by MDPI AG in Brain Sciences
- Vol. 10 (11) , 895
Abstract
The recreational use of opioid drugs is a global threat to public health and safety. In particular, an epidemic of opioid overdose fatalities is being driven by illicitly manufactured fentanyl, while novel synthetic opioids (NSOs) are appearing on recreational drug markets as standalone products, adulterants in heroin, or ingredients in counterfeit drug preparations. Trans-3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide (U-47700) is a prime example of a non-fentanyl NSO that is associated with numerous intoxications and fatalities. Here, we review the medicinal chemistry, preclinical pharmacology, clandestine availability, methods for detection, and forensic toxicology of U-47700 and its analogs. An up-to-date summary of the human cases involving U-47700 intoxication and death are described. The evidence demonstrates that U-47700 is a potent μ-opioid receptor agonist, which poses a serious risk for overdosing and death. However, most analogs of U-47700 appear to be less potent and have been detected infrequently in forensic specimens. U-47700 represents a classic example of how chemical entities from the medicinal chemistry or patent literature can be diverted for use in recreational drug markets. Lessons learned from the experiences with U-47700 can inform scientists, clinicians, and policymakers who are involved with responding to the spread and impact of NSOs.Keywords
Funding Information
- National Institutes of Health (DA000523-13)
This publication has 103 references indexed in Scilit:
- A Review of the Properties of Spiradoline: A Potent and Selective k‐Opioid Receptor AgonistCNS Drug Reviews, 2003
- Conformational Analysis and Automated Receptor Docking of Selective Arylacetamide-Based κ-Opioid AgonistsJournal of Medicinal Chemistry, 1998
- Synthesis and receptor binding of enantiomeric N-substituted cis-N-[2-(3,4-dichlorophenyl)ethyl]-2-(1-pyrrolidinyl)cyclohexylamines as high-affinity .sigma. receptor ligandsJournal of Medicinal Chemistry, 1991
- Alterations in the stereochemistry of the .kappa.-selective opioid agonist U50,488 result in high-affinity .sigma. ligandsJournal of Medicinal Chemistry, 1989
- Highly selective .kappa. opioid analgesics. Synthesis and structure-activity relationships of novel N-[(2-aminocyclohexyl)aryl]acetamide and N-[(2-aminocyclohexyl)aryloxy]acetamide derivativesJournal of Medicinal Chemistry, 1988
- Synthesis and structure-activity relationships of 1-substituted 4-(1,2-diphenylethyl)piperazine derivatives having narcotic agonist and antagonist activityJournal of Medicinal Chemistry, 1987
- Properties of a selective kappa agonist, U-50,488HLife Sciences, 1982
- Benzeneacetamide amines: structurally novel non-m.mu. opioidsJournal of Medicinal Chemistry, 1982
- 1-Substituted 4-(1,2-diphenylethyl)piperazine derivatives and their analgesic activities. 1Journal of Medicinal Chemistry, 1975
- 1-(3,4-Dichlorobenzamidomethyl)cyclohexyldimethylamine and related compounds as potential analgesicsJournal of Medicinal Chemistry, 1974